EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nano-Drug Delivery Systems for Bone Metastases: Targeting the Tumor–Bone Microenvironment

Mohamad Bakir, Ahmad Dawalibi iD, Mohammad Alaa Mufti, Ayman Behiery, Khalid S Mohammad iD

Pharmaceutics · 02.05.2025 · 17 (5) · 603

DOI: 10.3390/pharmaceutics17050603 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 02.05.2025. Verfasst von Mohamad Bakir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone metastases are a prevalent and debilitating consequence of various cancers, including breast and prostate carcinomas, which significantly compromise patient quality of life due to pain, fractures, and other skeletal-related events (SREs). This review examines the pathophysiology of bone metastases, emphasizing the role of the bone microenvironment in tumor progression through mechanisms such as osteotropism and the dysregulated bone remodeling cycle. The primary focus is on the emerging nano-drug delivery systems (DDS) designed to target the bone microenvironment and improve the therapeutic index of anticancer agents. Current treatments, mainly comprising bisphosphonates and radiotherapy, provide palliative benefits but often have limited efficacy and significant side effects. Innovative strategies, such as bisphosphonate-conjugated nanoparticles and targeted therapies that utilize the unique bone marrow niche, are explored for their potential to enhance drug accumulation at metastatic sites while minimizing systemic toxicity. These approaches include the use of liposomes, polymeric nanoparticles, and inorganic nanoparticles, which can be functionalized to exploit the biological barriers within the bone microenvironment. This review also discusses the challenges and future directions for nano-DDS in clinical settings, emphasizing the need for multidisciplinary research to effectively integrate these technologies into standard care protocols.

Schlagwörter

Stichwörter der Autor:innen

bone metastasesbone-targeting nanoparticlesnano-therapeutics for bone metastasisnanocarrier systemsnanoparticles in oncologytargeted drug delivery

Autor:innen und Institutionen

  • Department of Medicine, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
  • Department of Anatomy, College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.

ORCID-Profile: Ahmad Dawalibi, Khalid S Mohammad

Zitieren

APA

Bakir, M., Dawalibi, A., Mufti, M. A., Behiery, A., & Mohammad, K. S. (2025). Nano-Drug Delivery Systems for Bone Metastases: Targeting the Tumor–Bone Microenvironment. Pharmaceutics, 17(5), 603. https://doi.org/10.3390/pharmaceutics17050603

Vancouver

Bakir M, Dawalibi A, Mufti MA, Behiery A, Mohammad KS. Nano-Drug Delivery Systems for Bone Metastases: Targeting the Tumor–Bone Microenvironment. Pharmaceutics. 2025;17(5):603. doi:10.3390/pharmaceutics17050603

BibTeX
@article{Bakir2025,
  author = {Bakir, Mohamad and Dawalibi, Ahmad and Mufti, Mohammad Alaa and Behiery, Ayman and Mohammad, Khalid S},
  title = {Nano-Drug Delivery Systems for Bone Metastases: Targeting the Tumor–Bone Microenvironment},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {603},
  doi = {10.3390/pharmaceutics17050603}
}
Kostenlos starten →